Sectors & IndustriesHealthcareMedical Devices
Best Medical Device Stocks to Buy Now (2026)
Top medical device stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +28.50% per year, and are the best medical device stocks to buy now. Learn More.

Industry: Medical Devices
C
Medical Devices is Zen Rated C and is the 73rd ranked industry out of 145 stock market industries
Learn how the Zen Ratings work
Ticker
Company
Zen Rating
Sentiment
Market Cap
Shares
Institutional %
Insider %
Net Insider (L12M)
Net Insider (L3M)
ELMD
ELECTROMED INC
$348.09M8,280,06434.13%65.87%Net SellingNet Selling
LIVN
LIVANOVA PLC
$4.17B55,093,50791.25%8.75%Net SellingNet Selling
BVS
BIOVENTUS INC
$1.18B84,091,88038.73%61.27%Net Selling
TCMD
TACTILE SYSTEMS TECHNOLOGY INC
$650.97M22,556,26076.33%23.67%Net SellingNet Selling
ANIK
ANIKA THERAPEUTICS INC
$269.80M13,382,96681.28%18.72%Net SellingNet Selling
NSYS
NORTECH SYSTEMS INC
$40.02M2,794,5341.87%98.13%
VMD
VIEMED HEALTHCARE INC
$362.60M38,088,22865.27%13.97%Net SellingNet Selling
GKOS
GLAUKOS CORP
$10.09B58,983,93766.37%33.63%Net BuyingNet Buying
CNMD
CONMED CORP
$1.49B29,951,24897.17%2.83%Net Selling
BRKR
BRUKER CORP
$7.81B152,359,31654.82%45.18%Net SellingNet Buying
MDT
MEDTRONIC PLC
$109.98B1,280,045,19085.54%0.61%Net SellingNet Selling
SYK
STRYKER CORP
$129.43B383,573,04646.54%53.46%Net SellingNet Selling
PHG
KONINKLIJKE PHILIPS NV
$25.35B962,920,1325.32%0.00%
DXCM
DEXCOM INC
$31.33B377,360,76595.23%4.77%Net SellingNet Selling
CERS
CERUS CORP
$467.54M201,524,89875.22%8.16%Net SellingNet Selling
GMED
GLOBUS MEDICAL INC
$11.01B135,744,62677.79%22.21%Net BuyingNet Buying
SGHT
SIGHT SCIENCES INC
$390.57M55,087,99040.89%56.52%Net SellingNet Selling
IART
INTEGRA LIFESCIENCES HOLDINGS CORP
$1.33B77,772,50666.54%33.46%Net SellingNet Selling
SNN
SMITH & NEPHEW PLC
$13.03B877,724,8453.63%0.00%
STE
STERIS PLC
$22.62B97,602,48596.42%0.99%Net SellingNet Selling
VREX
VAREX IMAGING CORP
$515.73M42,100,00097.99%2.01%Net Selling
AXGN
AXOGEN INC
$2.38B53,761,51364.12%35.88%Net SellingNet Buying
ATEC
ALPHATEC HOLDINGS INC
$1.42B154,451,07624.56%75.44%Net SellingNet Buying
ALGN
ALIGN TECHNOLOGY INC
$12.01B71,039,85285.55%14.45%Net Selling
BWAY
BRAINSWAY LTD
$612.94M39,165,80629.91%25.47%
PODD
INSULET CORP
$9.66B69,354,19979.78%20.22%Net SellingNet Buying
NVCR
NOVOCURE LTD
$1.83B116,445,84060.05%39.95%Net SellingNet Selling
ZBH
ZIMMER BIOMET HOLDINGS INC
$18.54B190,737,68975.87%24.13%Net SellingNet Selling
EW
EDWARDS LIFESCIENCES CORP
$51.48B576,400,00087.41%1.27%Net SellingNet Selling
LMRI
LUMEXA IMAGING HOLDINGS INC
$1.10B96,080,73533.25%0.64%Net BuyingNet Buying
IRTC
IRHYTHM HOLDINGS INC
$4.21B32,862,40877.90%22.10%Net SellingNet Selling
DCTH
DELCATH SYSTEMS INC
$534.05M34,521,64740.12%59.88%Net Buying
SIBN
SI-BONE INC
$813.01M44,818,57558.49%41.51%Net SellingNet Selling
IRMD
IRADIMED CORP
$1.17B12,786,99159.60%39.26%Net SellingNet Selling
OFIX
ORTHOFIX MEDICAL INC
$431.77M40,732,60870.58%29.42%Net BuyingNet Selling
APYX
APYX MEDICAL CORP
$174.20M41,873,95149.70%21.12%Net BuyingNet Buying
MASS
908 DEVICES INC
$313.85M37,813,62151.71%48.29%Net SellingNet Selling
AHCO
ADAPTHEALTH CORP
$824.20M136,344,19645.46%54.54%Net BuyingNet Selling
BSX
BOSTON SCIENTIFIC CORP
$71.45B1,449,229,52692.53%5.83%Net SellingNet Buying
BFLY
BUTTERFLY NETWORK INC
$2.21B266,285,18352.22%43.07%Net SellingNet Selling
MOVE
CORVEX INC
$24.05M1,981,0470.41%99.59%Net BuyingNet Buying
ABT
ABBOTT LABORATORIES
$186.81B1,730,383,29679.46%1.17%Net SellingNet Selling
UFPT
UFP TECHNOLOGIES INC
$2.41B7,736,93987.09%12.91%Net SellingNet Selling
KIDS
ORTHOPEDIATRICS CORP
$596.09M26,109,78842.08%57.92%Net Selling
CTKB
CYTEK BIOSCIENCES INC
$540.73M129,983,25365.45%21.28%Net SellingNet Selling
MYO
MYOMO INC
$51.89M39,607,85432.31%17.85%Net BuyingNet Buying
BIO
BIO-RAD LABORATORIES INC
$9.16B26,738,17524.13%75.87%Net SellingNet Selling
MXCT
MAXCYTE INC
$118.91M107,121,67260.85%12.46%Net Buying
ESTA
ESTABLISHMENT LABS HOLDINGS INC
$2.33B29,430,39082.72%17.28%Net SellingNet Selling
SNWV
SANUWAVE HEALTH INC
$51.59M8,598,97648.38%24.98%Net Selling
NPCE
NEUROPACE INC
$473.90M34,093,74548.30%51.70%Net SellingNet Buying
INMD
INMODE LTD
$890.61M58,903,00056.92%12.90%
AORT
ARTIVION INC
$1.29B48,543,35080.30%19.70%Net SellingNet Buying
PROF
PROFOUND MEDICAL CORP
$288.52M36,337,63744.96%1.62%
INGN
INOGEN INC
$175.71M27,074,51668.59%31.41%Net SellingNet Selling
LUNG
PULMONX CORP
$88.04M42,948,26973.93%20.51%Net SellingNet Selling
PEN
PENUMBRA INC
$12.80B39,389,42285.92%10.38%Net Selling
CV
CAPSOVISION INC
$344.75M49,963,5867.99%30.00%Net BuyingNet Buying
TNDM
TANDEM DIABETES CARE INC
$1.29B68,529,08967.64%32.36%Net SellingNet Selling
INSP
INSPIRE MEDICAL SYSTEMS INC
$1.70B28,910,37566.90%33.10%Net SellingNet Selling
CBLL
CERIBELL INC
$692.45M37,942,70074.81%25.19%Net SellingNet Selling
RCEL
AVITA MEDICAL INC
$146.19M30,776,68996.83%3.17%Net BuyingNet Buying
HYPR
HYPERFINE INC
$97.48M99,270,33614.07%28.52%Net SellingNet Selling
SI
SHOULDER INNOVATIONS INC
$465.16M20,738,22630.70%69.30%Net BuyingNet Selling
QTRX
QUANTERIX CORP
$180.42M47,105,98165.24%34.76%Net BuyingNet Buying
ECOR
ELECTROCORE INC
$55.58M8,295,7075.75%94.25%Net SellingNet Buying
ALMR
ALAMAR BIOSCIENCES INC
$1.95B69,311,1860.00%10.67%Net Buying
SSII
SS INNOVATIONS INTERNATIONAL INC
$742.49M200,131,5350.67%99.33%Net BuyingNet Selling
HSDT
SOLANA CO
$98.09M58,386,67515.20%84.80%Net BuyingNet Buying
QDEL
QUIDELORTHO CORP
$1.11B68,190,98981.24%18.76%Net BuyingNet Selling
TLSI
TRISALUS LIFE SCIENCES INC
$299.10M61,416,53533.90%41.16%Net BuyingNet Buying
TMCI
TREACE MEDICAL CONCEPTS INC
$284.14M64,872,97644.31%55.69%Net BuyingNet Buying
MOBI
MOBIA MEDICAL INC
$409.63M33,249,0060.00%30.46%Net BuyingNet Buying
NUWE
NUWELLIS INC
$124.85k76,5932.11%97.89%
WOK
WORK MEDICAL TECHNOLOGY GROUP LTD
$215.001040.09%99.91%Net SellingNet Selling
CVRX
CVRX INC
$157.62M26,535,94440.14%59.86%Net Selling
AEMD
AETHLON MEDICAL INC
$1.43M474,1120.22%99.78%Net BuyingNet Selling
CODX
CO-DIAGNOSTICS INC
$5.12M3,602,4650.60%99.40%Net SellingNet Selling
NNOX
NANO-X IMAGING LTD
$70.99M69,600,78325.72%0.58%Net BuyingNet Buying
BBNX
BETA BIONICS INC
$634.80M44,989,68890.53%9.47%Net SellingNet Selling
LUCD
LUCID DIAGNOSTICS INC
$193.52M203,066,78317.54%21.14%Net BuyingNet Buying
OM
OUTSET MEDICAL INC
$96.39M18,537,24158.08%41.92%Net BuyingNet Buying
PACB
PACIFIC BIOSCIENCES OF CALIFORNIA INC
$361.85M310,601,68860.58%7.84%Net Selling
RXST
RXSIGHT INC
$252.89M41,593,25674.46%25.54%Net Buying
PMI
PICARD MEDICAL INC
$5.34M1,507,5104.75%95.25%
BJDX
BLUEJAY DIAGNOSTICS INC
$1.19M1,034,7150.60%99.40%Net BuyingNet Buying
MDAI
SPECTRAL AI INC
$52.83M31,823,98510.41%44.38%Net BuyingNet Buying
TMDX
TRANSMEDICS GROUP INC
$2.78B34,675,14577.87%22.13%Net BuyingNet Buying
CATX
PERSPECTIVE THERAPEUTICS INC
$338.72M114,046,19741.47%58.53%Net Buying
ICCM
ICECURE MEDICAL LTD
$8.33M2,706,00257.15%42.85%
LNSR
LENSAR INC
$69.42M12,104,32842.62%52.26%Net Selling
RPID
RAPID MICRO BIOSYSTEMS INC
$96.03M46,169,20233.10%66.90%Net BuyingNet Buying
PRCT
PROCEPT BIOROBOTICS CORP
$1.15B57,273,65975.50%24.50%Net BuyingNet Selling
SENS
SENSEONICS HOLDINGS INC
$215.29M41,802,9654.61%95.39%Net BuyingNet Selling
STEX
STREAMEX CORP
$75.39M104,274,81722.63%21.00%Net BuyingNet Buying
CLPT
CLEARPOINT NEURO INC
$408.45M30,504,22742.60%25.36%Net SellingNet Selling
CNSY
CERENOME INC
$26.57M6,883,10628.02%71.98%Net Buying
NVNO
ENVVENO MEDICAL CORP
$6.93M682,7220.91%99.09%Net SellingNet Selling
ELUT
ELUTIA INC
$38.95M44,208,23627.60%72.40%Net BuyingNet Selling
SINT
SINTX TECHNOLOGIES INC
$7.04M4,319,2795.16%70.88%Net Buying

Medical Device Stocks FAQ

What are the best medical device stocks to buy right now in Aug 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best medical equipment stocks to buy right now are:

1. Electromed (NYSEMKT:ELMD)


Electromed (NYSEMKT:ELMD) is the #1 top medical device stock out of 135 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Electromed (NYSEMKT:ELMD) is: Value: C, Growth: C, Momentum: B, Sentiment: A, Safety: B, Financials: A, and AI: C.

Electromed (NYSEMKT:ELMD) has a Due Diligence Score of 52, which is 22 points higher than the medical device industry average of 30.

ELMD passed 18 out of 33 due diligence checks and has strong fundamentals. Electromed has seen its stock return 128.11% over the past year, overperforming other medical device stocks by 228 percentage points.

Electromed has an average 1 year price target of $38.00, a downside of -9.61% from Electromed's current stock price of $42.04.

Electromed stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Electromed, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Livanova (NASDAQ:LIVN)


Livanova (NASDAQ:LIVN) is the #2 top medical device stock out of 135 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Livanova (NASDAQ:LIVN) is: Value: B, Growth: B, Momentum: C, Sentiment: B, Safety: A, Financials: B, and AI: C.

Livanova (NASDAQ:LIVN) has a Due Diligence Score of 41, which is 11 points higher than the medical device industry average of 30.

LIVN passed 13 out of 33 due diligence checks and has strong fundamentals. Livanova has seen its stock return 60.01% over the past year, overperforming other medical device stocks by 159 percentage points.

Livanova has an average 1 year price target of $85.50, an upside of 12.83% from Livanova's current stock price of $75.78.

Livanova stock has a consensus Buy recommendation according to Wall Street analysts. Of the 6 analysts covering Livanova, 16.67% have issued a Strong Buy rating, 50% have issued a Buy, 33.33% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Bioventus (NASDAQ:BVS)


Bioventus (NASDAQ:BVS) is the #3 top medical device stock out of 135 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Bioventus (NASDAQ:BVS) is: Value: B, Growth: B, Momentum: B, Sentiment: C, Safety: B, Financials: A, and AI: C.

Bioventus (NASDAQ:BVS) has a Due Diligence Score of 44, which is 14 points higher than the medical device industry average of 30.

BVS passed 14 out of 33 due diligence checks and has strong fundamentals. Bioventus has seen its stock return 91.77% over the past year, overperforming other medical device stocks by 191 percentage points.

Bioventus has an average 1 year price target of $15.00, an upside of 7.3% from Bioventus's current stock price of $13.98.

Bioventus stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Bioventus, 33.33% have issued a Strong Buy rating, 66.67% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the medical device stocks with highest dividends?

Out of 9 medical device stocks that have issued dividends in the past year, the 3 medical device stocks with the highest dividend yields are:

1. Koninklijke Philips Nv (NYSE:PHG)


Koninklijke Philips Nv (NYSE:PHG) has an annual dividend yield of 3.85%, which is 2 percentage points higher than the medical device industry average of 1.54%. Koninklijke Philips Nv's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Koninklijke Philips Nv's dividend has shown consistent growth over the last 10 years.

Koninklijke Philips Nv's dividend payout ratio of -109.6% indicates that its high dividend yield might not be sustainable for the long-term.

2. Smith & Nephew (NYSE:SNN)


Smith & Nephew (NYSE:SNN) has an annual dividend yield of 2.59%, which is 1 percentage points higher than the medical device industry average of 1.54%. Smith & Nephew's dividend payout is not stable, having dropped more than 10% nine times in the last 10 years. Smith & Nephew's dividend has shown consistent growth over the last 10 years.

Smith & Nephew's dividend payout ratio of 51.9% indicates that its dividend yield is sustainable for the long-term.

3. Abbott Laboratories (NYSE:ABT)


Abbott Laboratories (NYSE:ABT) has an annual dividend yield of 2.3%, which is 1 percentage points higher than the medical device industry average of 1.54%. Abbott Laboratories's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Abbott Laboratories's dividend has shown consistent growth over the last 10 years.

Abbott Laboratories's dividend payout ratio of 80% indicates that its dividend yield is sustainable for the long-term.

Why are medical device stocks down?

Medical device stocks were down -0.48% in the last day, and up 2.36% over the last week. Establishment Labs Holdings was the among the top losers in the medical devices industry, dropping -13.37% yesterday.

Establishment Labs Holdings shares are trading lower after the company reported mixed Q2 financial results.

What are the most undervalued medical device stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued medical device stocks right now are:

1. Inmode (NASDAQ:INMD)


Inmode (NASDAQ:INMD) is the most undervalued medical device stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Inmode has a valuation score of 71, which is 58 points higher than the medical device industry average of 13. It passed 5 out of 7 valuation due diligence checks.

Inmode's stock has gained 8.15% in the past year. It has overperformed other stocks in the medical device industry by 108 percentage points.

2. Conmed (NYSE:CNMD)


Conmed (NYSE:CNMD) is the second most undervalued medical device stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Conmed has a valuation score of 29, which is 16 points higher than the medical device industry average of 13. It passed 2 out of 7 valuation due diligence checks.

Conmed's stock has dropped -2.53% in the past year. It has overperformed other stocks in the medical device industry by 97 percentage points.

3. Koninklijke Philips Nv (NYSE:PHG)


Koninklijke Philips Nv (NYSE:PHG) is the third most undervalued medical device stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Koninklijke Philips Nv has a valuation score of 14, which is 1 points higher than the medical device industry average of 13. It passed 1 out of 7 valuation due diligence checks.

Koninklijke Philips Nv's stock has gained 0.5% in the past year. It has overperformed other stocks in the medical device industry by 100 percentage points.

Are medical device stocks a good buy now?

64.36% of medical device stocks rated by analysts are a strong buy right now. On average, analysts expect medical device stocks to rise by 28.09% over the next year.

6.19% of medical device stocks have a Zen Rating of A (Strong Buy), 17.53% of medical device stocks are rated B (Buy), 53.61% are rated C (Hold), 19.59% are rated D (Sell), and 3.09% are rated F (Strong Sell).

What is the average p/e ratio of the medical devices industry?

The average P/E ratio of the medical devices industry is 25.1x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.